Autosomal recessive cutis laxa type IIC is a rare genetic condition that affects skin, muscles, and connective tissue. People with Autosomal recessive cutis laxa type IIC often have loose, sagging skin, low muscle tone, joint laxity, and may have developmental delays. Features usually begin in infancy and are lifelong, but severity can vary among families. Treatment focuses on supportive care like physical and occupational therapy, skin protection, and monitoring for hernias or breathing problems. The outlook depends on the degree of organ involvement, and many living with Autosomal recessive cutis laxa type IIC benefit from coordinated specialty care.
Overview
Autosomal recessive cutis laxa type iicSymptoms
Autosomal recessive cutis laxa type IIC causes inelastic, sagging skin from birth or early infancy. Common features include low muscle tone, joint looseness, hernias, and delayed motor development. Some children also have distinctive facial features and growth concerns.
Outlook and prognosis
Many living with autosomal recessive cutis laxa type IIC have loose, fragile skin in childhood alongside muscle weakness and developmental delays. Progression varies; some gain skills slowly over time, while others need ongoing support for breathing, mobility, or nutrition. Coordinated care and early therapies can improve comfort, function, and quality of life.
Causes and risk factors
Autosomal recessive cutis laxa type IIC results from pathogenic changes in a single gene and is inherited when both parents are carriers. Risk is higher with a family history or parental relatedness. Environmental or lifestyle factors do not cause it.
Genetic influences
Genetics drive autosomal recessive cutis laxa type IIC; changes in the ATP6V0A2 gene disrupt elastic fiber formation. Both parents typically carry one silent variant. Genetic testing confirms the diagnosis, guides family planning, and helps estimate recurrence risk.
Diagnosis
Doctors diagnose autosomal recessive cutis laxa type IIC based on characteristic clinical features. Genetic tests confirm the genetic diagnosis of autosomal recessive cutis laxa type IIC, sometimes supported by imaging or a skin biopsy.
Treatment and drugs
Autosomal recessive cutis laxa type IIC care focuses on comfort, mobility, and organ support. Plans may include nutrition support, physical and occupational therapy, hernia repair, respiratory care, seizure management, and heart or gastrointestinal monitoring. Genetic counseling and coordinated specialty follow-up help families plan ahead.
Symptoms
Skin and joints can be looser than expected from early childhood, which can affect movement, feeding, and growth. Features vary from person to person and can change over time. Doctors may spot early features of Autosomal recessive cutis laxa type iic at birth or in the first year, such as sagging skin or a soft, floppy feel to the muscles. With routine care and therapies, many children make steady progress.
In Autosomal recessive cutis laxa type iic, skin may look saggy or wrinkled around the neck, tummy, and limbs. It often stretches easily and springs back slowly. Folds can rub and get irritated in warm weather.
Joints can bend further than usual and feel unstable in Autosomal recessive cutis laxa type iic. This may lead to sprains, flat feet, or delays with sitting and walking. Supportive shoes or braces can help.
Babies may feel floppy when held and have a weak grip. They may tire quickly during feeding or play. Physical and occupational therapy often build strength over time.
In Autosomal recessive cutis laxa type iic, sitting, crawling, walking, or first words may arrive later than peers. Many children catch on with early therapies and tailored education. Progress is usually steady, though pace varies.
How people usually first notice Autosomal recessive cutis laxa type iic?
Many families first notice autosomal recessive cutis laxa type IIC in infancy when a baby’s skin looks unusually loose or saggy, especially on the face, neck, and trunk, and doesn’t snap back easily after gentle stretching. Doctors may also pick up early features such as soft, doughy skin with visible folds, low muscle tone, and delayed motor milestones, and some babies show hernias or joint laxity that prompt evaluation. These first signs of autosomal recessive cutis laxa type IIC often lead to a genetics referral and testing when clinicians recognize the pattern of lax skin plus connective‑tissue findings.
Types of Autosomal recessive cutis laxa type iic
Autosomal recessive cutis laxa type IIC is a genetic condition with recognized subtypes based on the specific gene involved, which can shape age of onset and how the skin, muscles, nerves, and other organs are affected. Clinicians often describe them in these categories: ATP6V0A2-related, PYCR1-related, ALDH18A1-related, and other rare gene variants that disrupt connective tissue and cellular metabolism. Not everyone will experience every type. Understanding the types of autosomal recessive cutis laxa can help explain why symptoms such as loose, inelastic skin, growth differences, or developmental concerns vary from person to person.
ATP6V0A2-related
Loose, wrinkled skin is common from infancy and may be paired with feeding difficulties and hernias. Some have delayed motor milestones and mild to moderate developmental challenges. Brain imaging can show structural changes in a subset.
PYCR1-related
Skin laxity often appears with distinctive facial features and variable joint looseness. Many have small stature and limb differences, and some develop early spine curvature. Learning is usually typical or mildly affected.
ALDH18A1-related
In addition to cutis laxa, people may have muscle weakness, joint laxity, and growth restriction. Some develop metabolic issues and eye findings such as drooping lids. Neurodevelopmental involvement can range from mild to more significant.
Other rare variants
Less common gene changes can produce similar skin laxity with differing degrees of neurologic, skeletal, or metabolic features. Symptoms don’t always look the same for everyone. Discussing the specific gene can clarify likely symptoms and long-term outlook.
What genetics can tell you about symptoms
People with autosomal recessive cutis laxa type IIC often have loose, inelastic skin, muscle weakness, and delayed development linked to mutations in the ATP6V0A2 gene, which disrupts how cells process and arrange elastic fibers and proteins. Some also develop hernias, joint laxity, and distinctive facial features.
Causes and risk factors
Autosomal recessive cutis laxa type iic happens when a child inherits two changed copies of a gene that helps form elastic tissue. Most often, both parents are healthy carriers, and the chance that both are carriers is higher when parents are related by blood. If both are carriers, each pregnancy has a 1 in 4 chance of an affected child. Environmental risk factors for Autosomal recessive cutis laxa type iic do not cause it, but secondhand smoke, frequent infections, or heavy sun exposure can worsen some features and breathing strain. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Autosomal recessive cutis laxa type IIC typically begins before birth, so risk is mostly set very early. At this time, no specific environmental risk factors for Autosomal recessive cutis laxa type IIC have been confirmed. Genes provide a baseline, but daily surroundings add new layers.
No specific exposures are proven to raise the chance of Autosomal recessive cutis laxa type IIC. Large studies have not identified consistent environmental triggers. Research is ongoing.
Older egg or sperm can slightly increase new gene changes in general. This effect does not appear to meaningfully change risk for Autosomal recessive cutis laxa type IIC. Age alone is unlikely to be a driver.
Infections during pregnancy such as rubella or cytomegalovirus can affect fetal development. They have not been shown to cause Autosomal recessive cutis laxa type IIC. Preventive care still protects overall pregnancy health.
Poorly controlled diabetes or thyroid disease can raise certain birth risks. There is no evidence these conditions increase the likelihood of Autosomal recessive cutis laxa type IIC. Good overall control supports pregnancy health.
Genetic risk factors
Genetic causes of autosomal recessive cutis laxa type IIC involve harmful changes in a single ARCL2C‑associated gene. A child usually needs to inherit one non‑working copy from each parent to develop the condition, while carriers generally have no symptoms. People with the same risk factor can have very different experiences. Genetic testing can confirm the exact change in a family and clarify recurrence risk.
Single‑gene cause: Pathogenic changes in one ARCL2C‑associated gene underlie the condition. Different families often have different variants in that same gene. These changes disrupt normal elastic tissue development.
Autosomal recessive pattern: A child must inherit two non‑working copies (one from each parent) to develop autosomal recessive cutis laxa type IIC. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance to be affected. Carriers typically have no symptoms.
Sibling risks: If one child has autosomal recessive cutis laxa type IIC, each full sibling has a 25% chance to also be affected in each pregnancy. Unaffected full siblings have a 2 in 3 chance to be carriers. Extended relatives may also carry the familial variant.
Consanguinity: Parents who are blood relatives are more likely to carry the same rare variant, increasing the chance of an affected child. This can raise the likelihood of autosomal recessive cutis laxa type IIC in a family. The overall risk still depends on the specific variant in that family.
Variant type matters: Different changes in the same gene can lead to milder or more severe features. This helps explain why symptoms can vary among people with autosomal recessive cutis laxa type IIC. Severity can differ even within the same family.
De novo variants rare: New genetic changes causing the condition in both copies are very unlikely. Most people with autosomal recessive cutis laxa type IIC inherit one non‑working copy from each carrier parent. Recurrence risk reflects parental carrier status rather than spontaneous changes.
Carrier frequency unknown: The exact carrier rate in the general population is not well defined for this rare condition. Risk is higher when there is a known familial variant in autosomal recessive cutis laxa type IIC. Family‑based testing refines individual risk.
Family variant testing: Identifying the exact gene change in an affected person allows precise carrier testing for relatives. This clarifies who is at risk of having a child with autosomal recessive cutis laxa type IIC. It also enables options for early diagnosis in future pregnancies.
Lifestyle risk factors
This is a genetic condition; everyday habits do not cause it, but they can influence symptoms and complications. Thoughtful choices can help protect fragile connective tissues, support strength, and lower risks like joint injury or hernias. Below are practical ways showing how lifestyle affects Autosomal recessive cutis laxa type iic in daily life.
Regular emollients and fragrance‑free cleansers can reduce skin dryness and tearing. Sun protection helps limit additional elastin damage and may slow worsening laxity.
Swimming, cycling, or PT‑guided exercises can build muscle tone and improve joint stability. Avoiding high‑strain or contact sports may lower risks of joint dislocations and skin overstretching.
Using proper lifting techniques and avoiding repetitive overextension can reduce sprains and subluxations. Supportive footwear and pacing activities may lessen joint pain and fatigue.
Keeping weight in a personalized healthy range reduces mechanical stress on lax skin and hypermobile joints. It can also decrease abdominal pressure that worsens or precipitates hernias.
Risk prevention
Autosomal recessive cutis laxa type IIC is a genetic condition, so you can’t prevent it outright, but you can lower the chance of complications and protect day‑to‑day health. Prevention is about lowering risk, not eliminating it completely. Knowing early symptoms of autosomal recessive cutis laxa type IIC can prompt timely care and support. Regular check-ins with your care team can fine‑tune these steps as needs change.
Families with autosomal recessive cutis laxa type IIC may benefit from carrier testing and preconception counseling. Prenatal and preimplantation options can be discussed to plan future pregnancies.
Staying up to date with routine vaccines helps prevent chest infections that can strain breathing. Ask about flu and pneumococcal shots according to your region’s schedule.
Good hand hygiene and prompt care for colds or coughs can reduce lower respiratory infections in people with autosomal recessive cutis laxa type IIC. Seek medical advice early if fever, fast breathing, or wheeze develops.
Keep a smoke‑free home and limit exposure to dust and strong fumes. This helps protect the airways and may reduce coughing and flare‑ups.
Transmission
Autosomal recessive cutis laxa type IIC is a genetic condition and isn’t contagious—it can’t be caught or spread through touch, coughing, or blood. The genetic transmission of Autosomal recessive cutis laxa type IIC follows an autosomal recessive pattern: a child is affected only when they inherit two nonworking copies of the gene, one from each parent. Parents who each carry one changed copy (carriers) usually have no symptoms, and with each pregnancy there is a 25% (1 in 4) chance the child will have the condition, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance the child will inherit neither change. In some families, a new genetic change can occur for the first time, but most cases happen when both parents are carriers.
When to test your genes
Consider genetic testing if you have loose, inelastic skin from infancy, growth or developmental concerns, joint laxity, or family history of autosomal recessive cutis laxa type IIC. Testing helps confirm the diagnosis, guide care for lungs, heart, and connective tissues, and inform carrier status. Couples with a prior affected child or consanguinity should test before pregnancy.
Diagnosis
For many families, the first clues come from loose, sagging skin in infancy, soft joints, or hernias that keep returning. Doctors look at these visible features and overall growth and development, then decide which tests can confirm Autosomal recessive cutis laxa type iic. Getting a diagnosis is often a turning point toward answers and support. Because this is a rare inherited condition, the genetic diagnosis of Autosomal recessive cutis laxa type iic is typically confirmed with targeted genetic tests after the clinical exam.
Doctors assess skin laxity, joint looseness, facial features, and the presence of hernias. They also note features versus symptoms, such as how the skin stretches on exam and how muscles feel in tone. These patterns guide which tests to order next.
Clinicians map out relatives with similar features or early symptoms and note any shared ancestry. A detailed family and health history can help connect patterns that point toward a recessive condition.
A multigene panel or exome sequencing looks for disease-causing variants on both copies of a relevant gene. Finding a clear change on each copy confirms the diagnosis and can inform family planning. Results also help tailor follow-up care and screening.
A small skin sample can show reduced or fragmented elastic fibers with special stains. While not always required, these findings support a cutis laxa diagnosis. The biopsy can also help distinguish it from other connective tissue disorders.
Stages of Autosomal recessive cutis laxa type iic
Autosomal recessive cutis laxa type iic does not have defined progression stages. Early symptoms of Autosomal recessive cutis laxa type iic can appear in infancy and may change as a child grows, but they don’t unfold in clear, step-by-step phases and can differ widely between people. Different tests may be suggested to help confirm the diagnosis, including a physical exam focused on skin and joints and genetic testing when available. Ongoing care usually involves periodic check-ins with specialists to track growth and development and to monitor skin, joints, and other features over time.
Outlook and prognosis
Daily life with autosomal recessive cutis laxa type IIC can vary widely—some children have loose, wrinkled skin and joint laxity that affect movement, while others also face muscle weakness, hernias, or breathing and feeding challenges early on. Everyone’s journey looks a little different. Over time, early symptoms of autosomal recessive cutis laxa type IIC may ease or become more manageable with supportive care like physical therapy, nutritional support, and help for lung or gastrointestinal issues. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Looking at the long-term picture can be helpful. Many living with autosomal recessive cutis laxa type IIC have a stable course, especially when complications are identified and managed early. The most serious risks usually come from lung problems, severe infections, or significant feeding difficulties that affect growth; when these are well controlled, survival into adolescence and adulthood is possible. Doctors call this the prognosis—a medical word for likely outcomes.
For families planning ahead, the focus is on monitoring growth, respiratory health, and mobility, then adjusting support as needs change. When thinking about the future, it helps to remember that new interventions—better pulmonary care, careful nutrition, and targeted therapies—have improved quality of life and day-to-day function for many people with autosomal recessive cutis laxa type IIC. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Day to day, the long-term picture often centers on how skin, development, and movement change with time. Autosomal recessive cutis laxa type IIC can affect multiple body systems, so the impact may shift as children grow into teens and adults. Long-term effects vary widely, and everyone’s path looks different, and ongoing support can help track changes. Some features soften or stabilize, while others may persist into adulthood.
Loose, inelastic skin often remains noticeable on the face, neck, and trunk. It may slowly tighten or become less prominent with age, but folds and early wrinkles can persist.
Feeding difficulties and slow weight gain in infancy can lead to smaller body size later on. Some continue to have low muscle bulk and a slender build.
Low muscle tone and joint looseness can delay sitting, standing, or walking. Balance and coordination may stay mildly limited, affecting running or sports.
Many have mild to moderate learning differences that persist into school years. Support needs can range from minimal adjustments to ongoing educational help.
How is it to live with Autosomal recessive cutis laxa type iic?
Living with autosomal recessive cutis laxa type IIC often means navigating loose, inelastic skin alongside challenges that can include muscle weakness, joint laxity, delayed motor milestones, and sometimes involvement of the lungs or other organs. Daily life may revolve around supportive therapies—physical and occupational therapy for strength and stability, careful skin and joint care, pacing to manage fatigue, and regular check-ins with specialists to monitor breathing, growth, and development. For many, routines work best when they’re predictable and flexible, with adaptive equipment and school or workplace accommodations helping preserve independence and comfort. Families, caregivers, and friends often become a close support network, learning safe handling techniques, celebrating incremental gains, and sharing the emotional load that comes with a rare, lifelong condition.
Treatment and drugs
Treatment for autosomal recessive cutis laxa type IIC focuses on easing symptoms, protecting organs, and supporting development rather than correcting the underlying gene change. Care is usually coordinated by a team—often including genetics, pulmonology, cardiology, neurology, physiotherapy, and nutrition—to monitor breathing, heart function, growth, joints, and skin, and to address problems early. Supportive care can make a real difference in how you feel day to day, such as physical and occupational therapy for low muscle tone and joint laxity, nutritional support for feeding or growth issues, and tailored schooling or developmental therapies. Doctors sometimes recommend a combination of lifestyle changes and drugs, for example inhaled medicines or airway clearance for lung problems, treatments for reflux or constipation, and standard therapies for seizures if they occur; surgeries may be considered for hernias or significant connective‑tissue complications. Because needs change over time, regular check‑ins help adjust the plan, and genetic counseling can guide family planning and connect you with resources.
Non-drug treatment
Autosomal recessive cutis laxa type iic care centers on protecting skin and joints, supporting breathing and feeding, and boosting day‑to‑day function. Non-drug treatments often lay the foundation for comfort, mobility, and development. Plans are tailored, since features can vary from mild to more complex, even within the same family. Starting supportive care early can help address challenges as they arise and reduce complications over time.
Gentle strengthening and balance work can improve stability in loose joints. Therapists also teach safe movement patterns to prevent strains.
Everyday skills like dressing, writing, and feeding are broken into manageable steps. Adaptive tools and hand‑strengthening exercises can make tasks easier.
Early intervention programs support language, motor, and social skills. This can be especially helpful when early symptoms of Autosomal recessive cutis laxa type iic include low muscle tone or delayed milestones.
Regular breathing checks help spot problems early, especially if the chest wall is lax or colds hit hard. A pulmonologist may recommend airway clearance techniques during illnesses.
Your genes may have an impact on how drugs work for you
Some medicines work differently in people with autosomal recessive cutis laxa type IIC because changes in genes can alter how the body processes or responds to drugs. Pharmacogenetic testing, when available, may guide dosing and reduce side effects.
Pharmacological treatments
Treatment focuses on easing day-to-day issues like breathing trouble, skin fragility, reflux, constipation, and infections that many families manage at home or with their care team. Because early symptoms of Autosomal recessive cutis laxa type iic can affect the lungs, feeding, or development, medicines are chosen to target those problems and prevent complications. Not everyone responds to the same medication in the same way. There is no single disease-specific drug, so care is personalized and adjusted over time.
Albuterol (salbutamol) opens airways to ease wheeze or shortness of breath. It can be used as needed via inhaler or nebulizer.
Budesonide or fluticasone reduce airway inflammation and help prevent flare-ups. They are taken daily if symptoms are frequent.
Omeprazole or lansoprazole lower stomach acid to ease heartburn, feeding discomfort, or cough from reflux. This can help weight gain and reduce nighttime waking.
Levetiracetam is often a first choice for seizures because it’s effective and well tolerated. Valproate or topiramate may be used if seizures persist.
Genetic influences
In autosomal recessive cutis laxa type IIC, the underlying cause is a change in a single gene that must be inherited from both parents. If both parents carry one changed copy, each pregnancy has a 25% chance of a child with the condition, a 50% chance of a child who is a carrier, and a 25% chance of a child who is not a carrier. A “carrier” means you hold the gene change but may not show symptoms. These gene changes affect how elastic and support fibers are formed in the body, which can lead to loose skin and other features doctors look for. Even within the same family, severity can differ, and because the genetic change is present from birth, early symptoms of Autosomal recessive cutis laxa type iic often appear in infancy. Genetic testing can confirm the specific change, identify carriers among relatives, and guide care and family planning through genetic counseling.
Is Autosomal recessive cutis laxa type iic genetic?
Genetics drive autosomal recessive cutis laxa type IIC; changes in the ATP6V0A2 gene disrupt elastic fiber formation. Both parents typically carry one silent variant. Genetic testing confirms the diagnosis, guides family planning, and helps estimate recurrence risk.
Pharmacogenetics—how genetics influence drug effects
For people living with Autosomal recessive cutis laxa type IIC, the inherited gene change confirms the condition and helps doctors anticipate which body systems need support, but it doesn’t yet point to a specific, gene‑targeted medicine. Most care uses familiar drugs to manage issues such as reflux, constipation, infections, seizures, or pain, and your individual drug‑response genes can influence which medicine and dose feel right. Genetic testing can sometimes identify how your body processes certain medicines, which may help tailor dosing for drugs like some seizure treatments or acid‑reflux medicines that are known to be affected by common metabolizer genes. The condition‑causing gene itself does not typically change how you clear medicines, so pharmacogenetic testing for Autosomal recessive cutis laxa type IIC usually focuses on general drug‑metabolism genes rather than the disease gene. Care around anesthesia and pain control is especially individualized; doctors consider airway, muscle tone, nutrition, and liver or kidney function alongside any available pharmacogenetic results. Genes are just part of the picture, and treatment choices still depend on age, other health conditions, and how you respond over time.
Interactions with other conditions
Colds, stomach bugs, or chest infections can hit harder if loose connective tissues affect the lungs, airways, or gut, making breathing or feeding more tiring for people with autosomal recessive cutis laxa type iic. A condition may “exacerbate” (make worse) symptoms of another, so a lingering cough can strain hernias, and constipation can put extra pressure on already weak abdominal tissues. Some may also have reflux or poor weight gain, and these can interact with common childhood illnesses by increasing dehydration risk or slowing recovery. If heart or lung involvement is present, flu, RSV, or COVID-19 can lead to more serious breathing problems than they might in children without underlying tissue weakness. Because features can overlap with certain congenital disorders of glycosylation, clinicians may coordinate care to separate what belongs to cutis laxa from issues caused by another condition. With careful care, many people live well despite having both cutis laxa features and common illnesses, especially when vaccines, early treatment of infections, and gentle bowel and cough management are in place.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of loose, inelastic skin in newborns that didn’t match typical aging or weight changes. Elders recalled babies with soft, slack skin who later showed joint looseness and hernias, while doctors puzzled over why these features clustered in certain relatives. In daily life, this meant parents adjusting clothing to avoid skin irritation and clinicians watching for breathing or feeding issues that sometimes followed.
First described in the medical literature as part of a broader group called cutis laxa, these early reports grouped many different conditions together. Over time, descriptions became more precise as clinicians noticed that some children had not only sagging skin but also joint hypermobility, developmental delays, and specific facial features. These repeated patterns hinted that Autosomal recessive cutis laxa type iic was its own condition within the larger cutis laxa family.
As medical science evolved, careful family histories showed an inheritance pattern in which unaffected parents could have more than one affected child, pointing to an autosomal recessive cause. Pathology studies and imaging added clues: changes in connective tissue structure, hernias, and, in some, involvement of muscles and nerves. The picture grew clearer, yet many children were still labeled simply as having “cutis laxa,” reflecting how challenging it was to sort out overlapping features by symptoms alone.
Advances in genetics transformed understanding. Researchers linked a subset of these cases to changes in a gene that helps cells process and fold proteins correctly, which in turn affects the quality of elastic fibers in skin and other tissues. This explained why people with Autosomal recessive cutis laxa type iic could have a mix of skin findings and body‑wide features, and why two parents without symptoms could have a child with the condition. Genetic testing made it possible to confirm the diagnosis, support families with counseling, and connect them with specialists early.
Once considered rare, now recognized as a distinct subtype, Autosomal recessive cutis laxa type iic has a clearer historical path: from scattered descriptions of loose skin in infancy to a defined genetic condition with recognizable patterns. Knowing the condition’s history helps explain why some adults were given broad labels years ago, while children today may receive a more specific name and care plan. Although the science has sharpened the definition, the core goal remains the same across decades: to understand the early symptoms of Autosomal recessive cutis laxa type iic and provide practical, compassionate support for those living with it.